Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focal HIFU Therapy in Localized Intermediate Risk Prostate Cancer
NCT03568188Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2018
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by Hospices Civils de Lyon. Primary endpoint: Patient proportion with controlled disease at 12 months. Started Sep 2018; status: completed.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03568188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568188.